Daiichi Sankyo Company Ltd (4568) - Financial and Strategic SWOT Analysis Review

Date: September 6, 2017
Pages: 62
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: DB4C12A2F14EN
Leaflet:

Download PDF Leaflet

Daiichi Sankyo Company Ltd (4568) - Financial and Strategic SWOT Analysis Review
Daiichi Sankyo Company Ltd (4568) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Daiichi Sankyo Company Ltd (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, and quasi-drugs. The company classified its business operations into two segments, namely, Daiichi Sankyo Group segment and Ranbaxy Group segment. The company markets its products directly through its Japanese and global group companies. Daiichi Sankyo sells its products in more than 50 countries through a large network of medical representatives. The company operates across North America, South America, Europe and Asia Pacific. Daiichi Sankyo is headquartered in Tokyo, Japan.

Daiichi Sankyo Company Ltd Key Recent Developments

Sep 07,2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of October 1, 2017
Aug 01,2017: Daiichi Sankyo Announces Settlement Agreement on U.S. Products Liability Litigation
Jul 20,2017: Daiichi Sankyo Opens Applications for Investigator-Initiated Studies Program
Jul 18,2017: Zymeworks and Daiichi Sankyo Announce Successful Achievement of a Research Milestone in Bispecific Antibody Collaboration
Jul 11,2017: Daiichi Sankyo Selected for Ninth Consecutive Year as Constituent of FTSE4Good Global Index by FTSE Russell

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Daiichi Sankyo Company Ltd - Key Facts
Daiichi Sankyo Company Ltd - Key Employees
Daiichi Sankyo Company Ltd - Key Employee Biographies
Daiichi Sankyo Company Ltd - Major Products and Services
Daiichi Sankyo Company Ltd - History
Daiichi Sankyo Company Ltd - Company Statement
Daiichi Sankyo Company Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Daiichi Sankyo Company Ltd - Business Description
Daiichi Sankyo Company Ltd - Corporate Strategy
Daiichi Sankyo Company Ltd - SWOT Analysis
SWOT Analysis - Overview
Daiichi Sankyo Company Ltd - Strengths
Daiichi Sankyo Company Ltd - Weaknesses
Daiichi Sankyo Company Ltd - Opportunities
Daiichi Sankyo Company Ltd - Threats
Daiichi Sankyo Company Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Daiichi Sankyo Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Daiichi Sankyo Company Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Daiichi Sankyo Company Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 01, 2017: Daiichi Sankyo Announces Settlement Agreement on U.S. Products Liability Litigation
Jul 20, 2017: Daiichi Sankyo Opens Applications for Investigator-Initiated Studies Program
Jul 18, 2017: Zymeworks and Daiichi Sankyo Announce Successful Achievement of a Research Milestone in Bispecific Antibody Collaboration
Jul 11, 2017: Daiichi Sankyo Selected for Ninth Consecutive Year as Constituent of FTSE4Good Global Index by FTSE Russell
Jul 03, 2017: 15th Takamine Memorial Daiichi Sankyo Prize Winner Announced
Jun 20, 2017: Daiichi Sankyo Selects Deloitte's ConvergeHEALTH Safety to Transform and Upgrade Global Drug Safety Platform
Jun 16, 2017: Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology 10th Annual Clinical Pharmacology Research Award
Jun 15, 2017: Daiichi Sankyo Launches New Generic Drugs through Its Daiichi Sankyo Espha Subsidiary
May 23, 2017: Daiichi Sankyo Cancer Enterprise Pipeline Data Showing Swift Progress in Precision Medicine for Breast Cancer to be Presented at 2017 American Society of Clinical Oncology Annual Meeting
Apr 27, 2017: Daiichi Sankyo Announces 15 Billion Yen Manufacturing Investment to Support Acceleration of Antibody Drug Conjugate Portfolio

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Daiichi Sankyo Company Ltd, Key Facts
Daiichi Sankyo Company Ltd, Key Employees
Daiichi Sankyo Company Ltd, Key Employee Biographies
Daiichi Sankyo Company Ltd, Major Products and Services
Daiichi Sankyo Company Ltd, History
Daiichi Sankyo Company Ltd, Subsidiaries
Daiichi Sankyo Company Ltd, Joint Venture
Daiichi Sankyo Company Ltd, Key Competitors
Daiichi Sankyo Company Ltd, Ratios based on current share price
Daiichi Sankyo Company Ltd, Annual Ratios
Daiichi Sankyo Company Ltd, Annual Ratios (Cont.1)
Daiichi Sankyo Company Ltd, Annual Ratios (Cont.2)
Daiichi Sankyo Company Ltd, Interim Ratios
Daiichi Sankyo Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Daiichi Sankyo Company Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Daiichi Sankyo Company Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Daiichi Sankyo Company Ltd, Performance Chart (2013 - 2017)
Daiichi Sankyo Company Ltd, Ratio Charts
Daiichi Sankyo Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Daiichi Sankyo Company Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Takeda Pharmaceutical Company Ltd
Taisho Pharmaceutical Holdings Co Ltd
Sumitomo Dainippon Pharma Co Ltd
Shionogi & Co Ltd
Otsuka Pharmaceutical Co Ltd
Mitsubishi Tanabe Pharma Corp
Merck & Co Inc
Chugai Pharmaceutical Co Ltd
Astellas Pharma Inc
Skip to top


Ask Your Question

Daiichi Sankyo Company Ltd (4568) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: